Thoratec Corp (THOR) 63.50 $THOR United States

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Thoratec Corp (THOR) 63.50 $THOR

United States Electromedical and Electrotherapeutic Apparatus Market Report 2016 - Analysis And Forecast to 2020
M2 - Mon Jan 25, 9:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/6mvcjq/u_s) has announced the addition of the "U.S. Electromedical And Electrotherapeutic Apparatus Market - Analysis And Forecast to 2020" report to their offering. The report provides an in-depth analysis of the U.S. Electromedical And Electrotherapeutic Apparatus market. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. In addition, the report contains insightful information about the industry, including industry life cycle, business locations, productivity, employment and many other crucial aspects. The Company Profiles section contains relevant data on the major players in the industry. Product coverage: - Electromedical equipment (including diagnostic, therapeutic, and patient monitoring equipment), excluding ionizing radiation equipment - Electronic hearing aids, complete units - Electromedical and electrotherapeutic apparatus manufacturing Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Overview 4. Domestic Production 5. Imports 6. Exports 7. Competitive Landscape 8. Company Profiles - St. Jude Medical - Zimmer Biomet Holdings - Varian Medical Systems - Medtronic - Hologic - Abbott Vascular - Zoll Medical Corporation - Cyberonics - Fujifilm Sonosite - Biomerieux - Masimo Corporation - Starkey Laboratories - Volcano Corporation - Philips Ultrasound - Thoratec Corporation - Nxstage Medical - Danaher Corporation - Abiomed - GE Medical Systems Information Technologies - Natus Medical Incorporated - Conmed Corporation - Pacesetter - Amplifon (usa) - Zimmer - Cynosure - Mindray Ds Usa - Orchid Orthopedic Solutions - Zoll Services - Datex-Ohmeda - Medtronic Minimed - Terumo Cardiovascular Systems Corporation - Nellcor Puritan Bennett Incorporated - Cardiac Pacemakers - Halyard Sales For more information visit http://www.researchandmarkets.com/research/6mvcjq/u_s
ZBH: 129.40 (+1.05), MASI: 59.90 (+0.47), MDT: 87.32 (+0.34), MDSY: 1.30 (-0.08), DHR: 81.19 (-0.25), CYBX: 69.95 (+0.86), BABY: 40.64 (+0.93), VAR: 96.41 (+0.52), VOLC: 17.99 (+0.01), STJ: 78.65 (+0.51), THOR: 63.50 (+0.05), HOLX: 38.51 (+0.05)

Global Bio-Implant Market 2016-2021 - Increasing awareness about cosmetic implants giving rise to global bio-implant market
M2 - Wed Jan 20, 10:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/7jx486/global) has announced the addition of the "Global Bio-Implant Market, By Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation And Forecast 2015 - 2021" report to their offering. Global bio-implant market is growing at a CAGR of 8% from 2015-2021 The market is driven by various factors which include global rise in adoption of bio-implants, increase in number of people suffering from disabilities. It is giving rise to higher number of amputation. Rising incidence and prevalence rate of CVD, CHD and other heart diseases is also driving the market growth. Additionally, with increasing adoption of prosthetic limbs across geographies and rise in awareness about ear implants, pacemakers and other bio-implants are creating huge scope for global bio-implant market. Market is segmented on the basis of materials which include material such as ceramics, metal, alloys, polymers and others. Global bio-implant market by material and its type are extensively adopted by major hospitals and clinics for bio-implants. Further the market is segmented on the basis of bio implants type which includes CVD implants, spinal implants, orthopedic and trauma, dental, ophthalmic and neurostimulators. Stents, cardiac implant, ear implant are expected to contribute highest among all the segments of global bio-implant market. With the advancement in technology and innovation due to research and development segments such as dental implants, orthopedic implants are expected to contribute better in next few years. Bio-implant market consists of some major companies which includes Medtronic Inc, Abbot laboratories, AAP implantate AG, Bausch & Lomb incorporated, Biomet Inc, Biotronik SE & Co. KG, Boston scientific corporation, Crook group Inc, CR Bard Inc, Toshiba Corporation and others. Key Topics Covered: 1. Introduction 2. Market overview 3. Market determinants 4. Sector Analysis 5. Market Segmentation 6. Competitive Landscape 7. Geographical analysis 8. Company Profiles - Medtronic Inc - Abbot laboratories - AAP implantate AG - Bausch & Lomb incorporated - Biomet Inc - Biotronik SE & Co. KG - Boston scientific corporation - Crook group Inc - CR Bard Inc - Toshiba Corporation - GE healthcare - Edwards lifesciences corporation - Endo health solutions Inc - Johnson & Johnson - Philips corporation - Stryker corporation - Integral lifesciences holdings corporation - Integrated orbital implants - Lifenet health Inc - Mimedx group Inc - Orthofix international N.V. - Smith & nephew, PLC - Zimmer holdings - Wright medical group incorporated - WL Gore & associates Inc - Tornier N.V. - Thoratec corporation - St. Jude medical Inc - Sorin S.P.A. - Intuitive surgicals For more information visit http://www.researchandmarkets.com/research/7jx486/global
JNJ: 119.32 (+0.24), BCR: 221.21 (-0.29), MDT: 87.32 (+0.34), THOR: 63.50 (+0.05), SYK: 115.60 (+0.37)

St. Jude Medical Completes Acquisition of Thoratec
BusinessWire - Thu Oct 08, 3:38PM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced it has completed the previously announced acquisition of Thoratec Corporation, a worldwide leader in mechanical circulatory support (MCS) technology for the treatment of advanced heart failure (HF).
STJ: 78.65 (+0.51), THOR: 63.50 (+0.05)

Varian (VAR) Receives FDA Clearance, CE Mark for VitalBeam
Zacks Equity Research - Zacks Investment Research - Thu Oct 08, 11:50AM CDT
Varian Medical Systems, Inc. (VAR) recently announced that its VitalBeam platform has received FDA clearance as well as CE Mark.
MASI: 59.90 (+0.47), VAR: 96.41 (+0.52), THOR: 63.50 (+0.05), NUVA: 66.74 (+0.68)

Thoratec's shareholders approves its acquisition by St. Jude Medical
M2 - Thu Oct 08, 5:19AM CDT
Thoratec (NasdaqGS:THOR) said on Wednesday that all proposals necessary for its acquisition by St. Jude Medical were approved at the former's shareholder meeting.
STJ: 78.65 (+0.51), THOR: 63.50 (+0.05)

Thoratec Shareholders Approve St. Jude Medical's Acquisition Of Thoratec
PR Newswire - Wed Oct 07, 3:15PM CDT
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today that all proposals necessary for St. Jude Medical, Inc.'s acquisition of Thoratec Corporation were approved by Thoratec Corporation's shareholders at its shareholder meeting held today.
STJ: 78.65 (+0.51), THOR: 63.50 (+0.05)

Varian to Add New Tool to Eclipse Treatment Planning System
Zacks Equity Research - Zacks Investment Research - Wed Oct 07, 1:15PM CDT
Varian Medical Systems Inc. (VAR) recently announced that it will incorporate a multi-criteria optimization (MCO) radiotherapy treatment planning tool into its Eclipse treatment planning system
MASI: 59.90 (+0.47), VAR: 96.41 (+0.52), THOR: 63.50 (+0.05), NUVA: 66.74 (+0.68)

IDEXX's Strong CAG Impresses, Stiff Competition Concerns
Zacks Equity Research - Zacks Investment Research - Tue Oct 06, 5:03PM CDT
On Oct 6 2015, we issued an updated research report on IDEXX Laboratories, Inc. (IDXX).
MASI: 59.90 (+0.47), GMED: 23.97 (+0.51), THOR: 63.50 (+0.05), IDXX: 114.09 (+0.93)

MedAssets: A Strong Buy on Extended Ties & Solid Q2 Results
Zacks Equity Research - Zacks Investment Research - Tue Oct 06, 1:35PM CDT
On Oct 6, Zacks Investment Research raised MedAssets, Inc. (MDAS) to a Zacks Rank #1 (Strong Buy).
MASI: 59.90 (+0.47), THOR: 63.50 (+0.05), MDAS: 31.35 (+0.01), NUVA: 66.74 (+0.68)

Accuray Extends Ties with RaySearch Laboratories, Stock Up
Zacks Equity Research - Zacks Investment Research - Tue Oct 06, 12:10PM CDT
Shares of Accuray Incorporated (ARAY) rallied 3.2% (or 17 cents) yesterday, following the news of its second long-term agreement with RaySearch Laboratories.
MASI: 59.90 (+0.47), THOR: 63.50 (+0.05), ARAY: 5.42 (+0.12), NUVA: 66.74 (+0.68)

Thoratec Highlights Clinical Events From The European Association For Cardio-Thoracic Surgery Conference
PR Newswire - Tue Oct 06, 7:21AM CDT
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, highlighted recent clinical presentations from the European Association for Cardio-Thoracic Surgery (EACTS) annual meeting in Amsterdam, including three presentations that build upon the positive initial data from the HeartMate 3 CE Mark trial that was recently presented at the Heart Failure Society of America conference.
THOR: 63.50 (+0.05)

HeartWare-Valtech Cardio Deal: Engaged Capital Not in Favor
Zacks Equity Research - Zacks Investment Research - Mon Oct 05, 1:45PM CDT
HeartWare Inc.'s (HTWR) Valtech Cardio takeover has been opposed through a letter by one of its top 20 shareholders ??? Engaged Capital
ANF: 17.02 (-0.30), STJ: 78.65 (+0.51), THOR: 63.50 (+0.05), HTWR: 58.20 (+0.22)

St. Jude Faces FDA Warning for Quality Issues at Atlanta Plant
Zacks Equity Research - Zacks Investment Research - Mon Oct 05, 12:50PM CDT
According to Reuters, St. Jude Medical Inc. (STJ) has been recently warned by the FDA regarding the quality of the heart failure monitor CardioMEMS HF systems that are manufactured at its Atlanta plant
MASI: 59.90 (+0.47), STJ: 78.65 (+0.51), THOR: 63.50 (+0.05), NUVA: 66.74 (+0.68)

Cardinal Health Buys Cordis, Fortifies Cardiovascular Hold
Zacks Equity Research - Zacks Investment Research - Mon Oct 05, 12:45PM CDT
Cardinal Health, Inc. (CAH) recently completed the acquisition of Johnson & Johnson's (JNJ) Cordis business unit for $1.944 billion which was announced in March this year
MASI: 59.90 (+0.47), CAH: 79.73 (+0.03), THOR: 63.50 (+0.05), NUVA: 66.74 (+0.68)

C.R. Bard Gains Full Ownership of Medicon, Expands in Japan
Zacks Equity Research - Zacks Investment Research - Fri Oct 02, 11:50AM CDT
Shares of C.R. Bard Inc. (BCR) climbed 2.1% to $190.22, following the signing of a definitive agreement to acquire Kobayashi Pharmaceutical's 50% stake in Medicon.
MASI: 59.90 (+0.47), BCR: 221.21 (-0.29), THOR: 63.50 (+0.05), NUVA: 66.74 (+0.68)

Pacific Biosciences Unveils Sequel System, Boosts Portfolio
Zacks Equity Research - Zacks Investment Research - Thu Oct 01, 3:15PM CDT
Pacific Biosciences of California Inc (PACB) recently launched Sequel system ??? a nucleic acid sequencing platform based on Single Molecule, Real-Time (SMRT) technology
RTIX: 3.40 (+0.08), PACB: 8.28 (-0.02), MASI: 59.90 (+0.47), THOR: 63.50 (+0.05)

Verisk Analytics Set to Join the S&P 500; Joy Global to Join S&P MidCap 400
PR Newswire - Wed Sep 30, 5:05PM CDT
S&P 500 constituent Joy Global Inc. (NYSE: JOY) will replace Thoratec Corp. (NASDAQ: THOR) in the S&P MidCap 400, and Verisk Analytics Inc. (NASDAQ: VRSK) will replace Joy Global in the S&P 500 after the close of trading on Wednesday, October 7. S&P 500 constituent St. Jude Medical Inc. (NYSE: STJ) is acquiring Thoratec in a deal expected to be completed on or about that date, pending final approvals. Joy Global has a market capitalization more representative of the mid-cap market space.
JOY: 27.26 (+0.01), VRSK: 83.84 (+0.54), STJ: 78.65 (+0.51), THOR: 63.50 (+0.05), MHFI: 107.92 (+1.16)

RTI Surgical: A Strong Buy on Q2 Results, Raised 2015 View
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 3:10PM CDT
On Sep 30, Zacks Investment Research upgraded RTI Surgical Inc. (RTIX) to a Zacks Rank #1 (Strong Buy).
ABMD: 117.43 (-0.20), RTIX: 3.40 (+0.08), MASI: 59.90 (+0.47), THOR: 63.50 (+0.05)

PRA Health, AMR Team Up to Advance Vaccine Studies
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 12:55PM CDT
PRA Health Sciences, Inc. (PRAH) recently announced a partnership with Alliance for Multispecialty Research (AMR) in order to bring new vaccines in the market
MASI: 59.90 (+0.47), THOR: 63.50 (+0.05), PRAH: 50.38 (-0.18), NUVA: 66.74 (+0.68)

Veeva's Zinc Ahead Deal: Focus on Compliance Management
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 12:45PM CDT
Provider of cloud-based software solutions, Veeva Systems (VEEV) recently took over Zinc Ahead for $130 million
VEEV: 40.74 (+0.51), MASI: 59.90 (+0.47), THOR: 63.50 (+0.05), NUVA: 66.74 (+0.68)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 108

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
U.S. Employers Signal a Deeper Multilingual Skills Gap

Updated Category News Views 101

A language gap rarely makes the loudest noise in an earnings call, yet it can quietly wreck a sales effort, a hiring plan, or a customer relationship. ACTFL's updated 2026 employer study puts some hard edges around that problem: U.S. businesses say multilingual capability is not a nice cultural accessory. It is increasingly part of operating the business. Demand Has Moved...

Continue Reading
AlphaPoint's Approval Device Targets AI Attack Risk

Updated Category News Views 45

A Separate Screen May Be Worth More Than Another Patch AlphaPoint is taking a fairly old security instinct and aiming it at a very current headache: if the laptop is lying to the employee, do not let the laptop have the final say. Its newly introduced Approval Device is dedicated hardware with its own display, built to let authorized staff inspect and approve sensitive...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 103

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
Water Damage Coverage Has More Traps Than Homeowners Think

Updated Category News Views 29

A wet basement does not care one bit whether the water arrived dramatically or dripped in for months. That ugly distinction, though, can decide whether a homeowner has an insurance claim or a repair bill that lands with a thud. Kathy Thurmond-Edwards, an insurance expert in Memphis, Tennessee, lays out the dividing lines plainly: sudden pipe failures may be treated very...

Continue Reading
Birkenstock’s Athens Stores Put Brand Control to Work

Updated Category News Views 76

A 62-square-meter shop on Ermou Street can say plenty about a brand’s ambitions. Birkenstock is opening its first two Greek stores in Athens, moving beyond its existing wholesale and retail-partner presence with locations it can shape from the floorboards up. The first site at Ermou 18 is stated to have opened on November 12, 2026; the announcement itself is dated...

Continue Reading
Trump's Reagan Forum Speech Puts Defense in Focus Again

Updated Category News Views 118

A December podium in Simi Valley has suddenly become a market-relevant appointment. The Ronald Reagan Presidential Foundation and Institute says President Donald J. Trump will deliver the keynote at the 2026 Reagan National Defense Forum on Friday, December 4, at 3:00 p.m. Pacific time, or 6:00 p.m. Eastern. That is the whole hard fact pattern so far. No agenda, no...

Continue Reading
PCS Rental Prep Is About Control Before Distance Hits

Updated Category News Views 99

A vacant house can turn into a long-distance headache with startling speed. For military homeowners preparing for a PCS move, the useful point in Rhonda Leahy's guidance is not glamorous: settle the boring operational stuff before the moving boxes, travel orders, and new-duty-station chaos swallow the calendar. Renting out a former home is not merely collecting enough...

Continue Reading
TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 73

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 62

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading

Top 5 Most Recently Viewed Articles

Redsun Properties Faces $350 Million Bond Payment Crisis Ahead

Updated Category News Views 189

Redsun Properties Announces Inability to Pay Bond Chinese property developer Redsun Properties has communicated its inability to meet a $350 million bond payment, which is due shortly. This situation has raised considerable concern within the financial markets as it highlights the ongoing issues facing property developers in China. Details of the Bond Issue This bond,...

Continue Reading
Etruscus Resources Unveils Promising Findings at Zappa Target

Updated Category News Views 135

Etruscus Resources Makes Progress at Key Exploration Sites Etruscus Resources Corp. is thrilled to report on the encouraging findings from its exploration program at the Rock & Roll Property. This property is situated in the Golden Triangle region, known for its wealth of mineral resources. The exploration program, which included comprehensive rock sampling and geological...

Continue Reading
MetLife's Strategic Focus: Navigating Q3 2024 Earnings

Updated Category News Views 1091

MetLife Announces Q3 2024 Results and New Frontier Strategy In the third quarter of 2024, MetLife, Inc. (MET) reported adjusted earnings of $1.4 billion, translating to $1.93 per share. This reflects a decline from previous year figures, yet a 12% year-to-date increase in adjusted earnings per share (EPS) excluding notable items. The insurance powerhouse has seen positive...

Continue Reading
VEON Invests in Ukraine: Commitment to Digital Growth

Updated Category News Views 125

VEON's Commitment to Investing in Ukraine VEON Ltd. (NASDAQ: VEON), a leading global digital operator, has recently made significant news with its promise to enhance Ukraine’s telecommunications infrastructure. In collaboration with its fully-owned subsidiary, Kyivstar, VEON participated in the 2024 Yalta European Strategy (YES) Annual Meeting. At this event, the focus...

Continue Reading
Expanding Diabetes Care: From Monitoring to Change

Updated Category News Views 44

Breaking Ground at the AGP & DTx Summit Diabetes management ain't what it used to be, and the 4th AGP & DTx Summit in Shenzhen gave us an eyeful of change. Under the banner "Beyond Glucose," experts from all corners came together to talk shop about Continuous Glucose Monitoring (CGM) and how it might shake up diabetes care. CGM: More Than a Gadget See, CGM's not just a...

Continue Reading